Seth Boydstun, MD
Orthopaedic Surgery · Oklahoma City, OKNPI 1598179111
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $26,115 with a category attached, or 76.6%. Arthrex accounts for 81.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $22,751 and has fallen 99.2% since, to $174 in 2025.
Across 53 payments — averaging $492.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$21K
- Pylant Medical$2K
- Micromed Inc$1K
- Stryker$419
- Medical Device Business Services, Inc.$319
- Zimmer Biomet$149
- plus $384 from 13 others
What the payments were for
- Grants$20,00077%
- Travel & lodging$4742%
- Food & beverage$1,9507%
- Education$3,69114%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 14 | $21,361 |
| Pylant Medical | 8 | $2,345 |
| Micromed Inc | 1 | $1,137 |
| Stryker | 9 | $419 |
| Medical Device Business Services, Inc. | 1 | $319 |
| Zimmer Biomet | 1 | $149 |
| Smith+Nephew | 3 | $56 |
| Innovation Technologies Inc | 2 | $50 |
| Bioventus LLC | 2 | $44 |
| Avanos Medical | 2 | $37 |
| Acera Surgical, Inc. | 1 | $34 |
| UCB, Inc. | 2 | $31 |
| ERMI LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Omnilife Science, Inc | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$149
How this compares
$26,115 in reported general payments places this provider in the 80th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 210 | $2,194 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 95 | $1,062 |
| Meloxicam | 205 | $846 |
| Tramadol Hcl | 42 | $180 |
| Ondansetron OdtOndansetron | 13 | $149 |
| Ibuprofen | 11 | $134 |
| Clindamycin Hcl | 19 | $122 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $83 |
| Gabapentin | 16 | $73 |
| Amoxicillin | 73 | $73 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Oklahoma City
- Andrew ParkinsonOklahoma City$3.1M
- Bradley ReddickOklahoma City$573K
- Jason EmersonOklahoma City$189K
- Ronald DumiganOklahoma City$169K
- Paul MaitinoOklahoma City$110K
- Thomas TkachOklahoma City$83K
- Brian LevingsOklahoma City$80K
- Christopher WhiteOklahoma City$73K
- Raymond SteinmetzOklahoma City$64K
- Michael JohnsonOklahoma City$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.